Evidera
Sharad Upadhyay currently serves as a Principal Medical Writer at Evidera, with experience in the medical writing field spanning over 17 years. Prior roles include Senior Consultant at IQVIA and various positions at Evidera, where responsibilities included preparing and reviewing clinical study reports and regulatory documents in compliance with ICH E3 guidelines. Sharad previously worked as a Senior Regulatory Writer at Tata Consultancy Services and held a position as Senior Executive in Clinical Research at Ranbaxy Research Labs. Earlier experience includes work as an Associate Medical Writer at Cognizant and as a Freelance Medical Writer. Educational qualifications comprise an M Pharma in Pharmacology from HIMT College of Pharmacy and multiple diplomas related to clinical trials, business administration, and drug regulatory affairs.
This person is not in any teams
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.